Michelle Frank

Michelle Frank has over 25 years of work experience in the pharmaceutical industry. Michelle is currently the Executive Director of Medical Strategy & Operations at Axsome Therapeutics, Inc. Previously, they worked at ACADIA Pharmaceuticals Inc. as the Director of Medical Affairs Operations from 2020 to 2023. Prior to that, they served as the Director of Program Management at Heron Therapeutics, Inc. from 2018 to 2020, at Intercept Pharmaceuticals from 2017 to 2018, and at Jazz Pharmaceuticals from 2015 to 2016. Michelle also has extensive experience at Amgen, where they held various roles including Global Program Manager, Senior Project Manager, and Clinical Study Planning Senior Manager from 2006 to 2015. Before joining Amgen, they worked at Takeda Pharmaceuticals, UK as a Project Manager from 2005 to 2006 and as a Clinical Project Scientist from 2004 to 2005. Michelle also has experience at Pharmacia Ltd as a Lead Medical Development Planner from 2001 to 2003, at GlaxoSmithKline plc as an International Study Team Leader from 1997 to 2001, and at Glaxo Wellcome South Africa (Pty) Ltd as a Clinical Research Associate from 1995 to 1996.

Michelle Frank attended the University of the Witwatersrand from 1990 to 1993, where they earned a Bachelor of Pharmacy (BPharm) degree in Pharmacy. Michelle also holds a certification in Project Management Professional from the Project Management Institute, but the specific details such as the month and year of obtaining the certification are not provided.